Previous Page  12 / 24 Next Page
Information
Show Menu
Previous Page 12 / 24 Next Page
Page Background

Page 72

conferenceseries

.com

Volume 8

Journal of Palliative Care & Medicine

ISSN: 2165-7386

Geriatrics 2018

July 30-31, 2018

July 30-31, 2018 | Barcelona, Spain

8

th

International Conference on

Geriatrics Gerontology & Palliative Nursing

Dementia-related agitation: A review of non-drug interventions and analysis of risks and benefits of

drug therapy

Ezekiel O Ijaopo

East Kent Hospitals University Trust, UK

Unsurprisingly, the subject of dementia has been a rising matter of public health concerns as people now live longer. World

Alzheimer Report 2015, estimate that about 46.8 million people worldwide have dementia. These numbers are projected to

almost double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. The modality for treating agitation

and other behavioral symptoms in dementia patients has been a challenge. Many years on, there has been no FDA-approved

drug therapy in treating dementia-related agitation. This review discusses the current knowledge of non-drug interventions

and analyzes the risks and benefits of drug therapy in the management of dementia-related agitation, as well as providing an

anecdotal of the author’s clinical experience. This article aims to provide opportunity for increase awareness for clinicians;

particularly those with no specialty training in elderly care medicine, but, see dementia patients with agitation and other

behavioral symptoms from time to time. Likewise, it hopefully will benefit the readers of medical journals to update their

existing knowledge on matters relating to the management of dementia-related agitation.

Ezekiel.ijaopo@nhs.net

J Palliat Care Med 2018, Volume 8

DOI: 10.4172/2165-7386-C2-018